Disclosing Pharmaceutical Company Windfall Profits Act of 2018
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 17, 2018
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
May 17, 2018
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Disclosing Pharmaceutical Company Windfall Profits Act of 2018
This bill amends the Securities Exchange Act of 1934 to require pharmaceutical companies to make certain public disclosures, including disclosures related to taxation, compensation, dividends, and spending on research and development.
What's happening now
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 2885: Disclosing Pharmaceutical Company Windfall Profits Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-S-2885/
"S. 2885: Disclosing Pharmaceutical Company Windfall Profits Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2885/.
S. 2885, 115th Cong. (2026), https://openamerica.io/bill/115-S-2885/.
[S. 2885: Disclosing Pharmaceutical Company Windfall Profits Act of 2018](https://openamerica.io/bill/115-S-2885/)